Walt Disney Co (NYSE:DIS) Is Not Buying Netflix, Inc. (NASDAQ:NFLX) In 2017 This Is Why

Walt Disney Co (NYSE:DIS) Is Not Buying Netflix, Inc. (NASDAQ:NFLX) In 2017 This Is Why

Walt Disney Co (NYSE:DIS) is not buying Netflix, Inc. (NASDAQ:NFLX) in 2017 for the basic reason that the merger will only lead to a conflict of interest given the two companies business model. The streaming giant impressive growth has come at the back of being able to stream content without paying preference to a particular production studio. That may not be the case if it agreed to be acquired by […]

Read More ˃
Relationship Between Walt Disney Co (NYSE:DIS) And Chinese Toymaker Sours Leading To Contract Termination

Relationship Between Walt Disney Co (NYSE:DIS) And Chinese Toymaker Sours Leading To Contract Termination

Walt Disney Co (NYSE:DIS) has cut off business ties with one of its Chinese toy manufacturers. The move by Walt Disney follows reports that the manufacturer was violating labor laws. News of the severance of ties between Disney and Chinese toymaker were first communicated in a memo that Disney posted online. The Chinese toy manufacturer was identified as Dongguan Qing Xi Juantiway Plastic Factory. The acts of labor violations by […]

Read More ˃
The Walt Disney Co (NYSE:DIS) Plows In Millions In Enhancing Transportation Projects

The Walt Disney Co (NYSE:DIS) Plows In Millions In Enhancing Transportation Projects

In every country, in every state, proper transportation is one of the key elements that fuels growth.  It is for this reason that Walt Disney Co (NYSE:DIS) World has resorted to making several improvements, which will ensure ease of movement for vehicles. In the next couple of years, the traffic snarls at the Magic Kingdom parking entrance, and the fender splurges with buses will be a thing of the past. […]

Read More ˃
Walt Disney Co (NYSE:DIS), Embattled By Fairytale Controversy

Walt Disney Co (NYSE:DIS), Embattled By Fairytale Controversy

In the latest Walt Disney Co (NYSE:DIS) controversy that is challenging the company, an unknown teacher in England has recently uploaded online a lesson plan entitled “Racism/Sexism in Disney” for students aged 11 to 16 years old. Walt Disney Controversy The lesson plan primarily teaches students that Walt Disney fairy tales promote racism and sexism, particularly targeting the upcoming Walt Disney motion picture, “Beauty and the Beast”. It has already […]

Read More ˃
Walt Disney Co (NYSE:DIS) Moana Movie Renamed In Italy Due To A Porn Star

Walt Disney Co (NYSE:DIS) Moana Movie Renamed In Italy Due To A Porn Star

Walt Disney Co (NYSE:DIS) Moana, the movies, renamed in Italy mainly due to being confused with a well-known porn star in the country. The film itself is a highly anticipated animated blockbuster, which is soon to be released in Italy. Despite the media sprawl on the topic, Disney has yet to place a comment on the impact that the adult actor played on the changing of the film name. However, […]

Read More ˃
Walt Disney Co (NYSE:DIS) Records 3rd 2016 Top-Grossing Film with Walt Disney Finding Dory

Walt Disney Co (NYSE:DIS) Records 3rd 2016 Top-Grossing Film with Walt Disney Finding Dory

Disney Finding Dory has recently topped $1 billion in the box office worldwide. Success of Disney Finding Dory With the success of the sequel of Walt Disney Finding Nemo, Walt Disney Co (NYSE:DIS) now has three billion-dollar-grossing motion pictures released this year alone. In the US, Walt Disney Finding Dory is the top-grossing film of 2016, bringing in $484 million. Internationally, it has already reached past the half-billion mark and […]

Read More ˃
A Look at Why RBC Capital Markets Lowered their Price Target on Flextronics International Ltd.(NASDAQ:FLEX) to $13 from $14.

A Look at Why RBC Capital Markets Lowered their Price Target on Flextronics International Ltd.(NASDAQ:FLEX) to $13 from $14.

On October 4 Equity Analysts Amit Daryanani, CFA, Mitch Steves and Associates Irvin Liu and Jeriel Ong of RBC Capital Markets Equity Research Lowered their Price Target on Flextronics International Ltd.(NASDAQ:FLEX) to $13 from $14. and Issued a report titled ”Adjusting Estimates To Reflect Challenging Macro In H2:15.” According to the report ”We are adjusting our estimates lower on FLEX to reflect multiple headwinds that we think will curtail revenue […]

Read More ˃
The Inside Scoop on Why Deutsche Bank Reiterated their $36 Buy Rating on TerraForm Power Inc(NASDAQ:TERP)

The Inside Scoop on Why Deutsche Bank Reiterated their $36 Buy Rating on TerraForm Power Inc(NASDAQ:TERP)

On October 4 research analyst Vishal Shah and research associate Jerimiah Booream-Phelps Reiterated their $36 Buy Rating on TerraForm Power Inc(NASDAQ:TERP) and issued a report titled ”Takeaways from Management Meeting.” Overall thoughts on the meeting were ”We walked away incrementally more positive after meeting TERP management team. We expect concerns over near term capital raise to fade over the next few months as the company executes on closing the VSLR […]

Read More ˃
Jefferies Reiterates $3.50 price target on AcelRx Pharmaceuticals Inc(NASDAQ:ACRX)

Jefferies Reiterates $3.50 price target on AcelRx Pharmaceuticals Inc(NASDAQ:ACRX)

Equity Research Firm Jefferies Reiterated its $3.50 price target on AcelRx Pharmaceuticals Inc(NASDAQ:ACRX) and Issued a Research Report titled ”ACRX: HOLD: Key Takeaways from R&D Day” on October 2. Equity Analysts Biren Amin, Hugo Ong, Ph.D., and Shaunak Deepak stated ”At its R&D Day, ACRX reviewed its pipeline portfolio which included a focus on ARX-04 which could be the next meaningful revenue opportunity. Based on clinical data and market research, […]

Read More ˃
BTIG Equity Research Reiterates $12 Price Target on Progenics Pharmaceuticals, Inc.(NASDAQ:PGNX)

BTIG Equity Research Reiterates $12 Price Target on Progenics Pharmaceuticals, Inc.(NASDAQ:PGNX)

Equity Analyst Hartaj Singh of BTIG Equity Research reiterated his $12 price target on Progenics Pharmaceuticals, Inc.(NASDAQ:PGNX) October 3 in a research report titled ”Pipeline Focus Increasing.” According to Hartaj Singh ”PGNX is more than a play on Relistor royalties, with three mid/late stage assets that are positioning the company closer to creating a valuation rerating. Company management continues to demonstrate that they are building franchises that meet important unmet […]

Read More ˃